GlobalData's EpiCast is a series of premier epidemiology reports and models written and developed by Masters and PhD-level epidemiologists.
Our EpiCast Reports and Models cover an unrivalled breadth and depth of data and key areas, including cardiovascular, the central nervous system, dermatology and gastrointestinal, as well as hematology, immunology, infectious diseases, metabolic disorders, oncology and respiratory. Countries covered include the US, Japan, France, Germany, Italy, Spain, the UK, India and China. Other countries covered, if relevant to the market, include Brazil, Canada and Australia.
EpiCast Reports provide expert analysis of epidemiological trends and forecasting of patient populations for major markets. High-quality, transparent and market-driven, they provide coverage on risk factors and co-morbidities; prevalence and/or incidence by country; age and gender segmentation; and global trends in incidence, prevalence and/or mortality.
In addition, EpiCast Reports provide a complete view of key markets and trends. Specifically, the reports identify disease trends over a ten-year forecast period in seven major markets (the US, France, Germany, Italy, Spain, the UK and Japan). Additional countries, such as Canada, Brazil, India and China, are covered in these reports if their markets are highly relevant.
EpiCast Models are robust, fully transparent, easy to navigate, user-friendly and epidemiology based with transparent and consistent methodologies. In addition, our models support data presented in the reports. Available free-of-charge with a site or global license of a report, our robust EpiCast Models support data presented in the reports and use transparent and consistent methodologies.
Models showcase disease population trends over a ten-year forecast period using reputable sources for seven major markets. The models will always include all countries covered in the corresponding report and in some instances will include epidemiology forecasts for additional countries.
Why choose EpiCast?
Our leading epidemiology intelligence assists in comprehensive strategic decision-making by providing market assessments, including market size and patient pool estimates, and detailed analytical reports on a particular therapy or indication.
Who can EpiCast reports and models help?
- Pharmaceutical companies
- Biotechnology companies